We are live on ! Find out more

Small Cap
Drug Manufacturers - Specialty & Generic
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
BCRX icon
1
BioCryst Pharmaceuticals
BCRX
$1.92B
$1.92B $7.45 0%
ETON icon
2
Eton Pharmaceutcials
ETON
$1.81B
$1.81B $62.79 1.71%
TRLV icon
3
Trulieve Cannabis
TRLV
$1.74B
$1.74B $10.17 1.55%
ANIP icon
4
ANI Pharmaceuticals
ANIP
$1.6B
$1.6B $70.61 0.39%
ALVO icon
5
Alvotech
ALVO
$1.58B
$1.58B $4.42 0.23%
PCRX icon
6
Pacira BioSciences
PCRX
$1.46B
$1.46B $36.48 0%
PAHC icon
7
Phibro Animal Health
PAHC
$1.42B
$1.42B $35.02 0%
AMPH icon
8
Amphastar Pharmaceuticals
AMPH
$1.23B
$1.23B $28.76 1.41%
CRON icon
9
Cronos Group
CRON
$1.19B
$1.19B $3.24 0.92%
HROW icon
10
Harrow
HROW
$1.11B
$1.11B $29.62 1.82%
IRWD icon
11
Ironwood Pharmaceuticals
IRWD
$806M
$806M $4.87 0.41%
COLL icon
12
Collegium Pharmaceutical
COLL
$792M
$792M $25.49 0.24%
EVO icon
13
Evotec
EVO
$522M
$522M $1.47 5.77%
TKNO icon
14
Alpha Teknova
TKNO
$488M
$488M $7.76 0.13%
AQST icon
15
Aquestive Therapeutics
AQST
$479M
$479M $3.81 1.33%
KMDA icon
16
Kamada
KMDA
$468M
$468M $8.11 0%
EOLS icon
17
Evolus
EOLS
$426M
$426M $6.43 3.02%
TLRY icon
18
Tilray
TLRY
$347M
$347M $2.35 0.43%
ACB icon
19
Aurora Cannabis
ACB
$301M
$301M $4.58 0.65%
EBS icon
20
Emergent Biosolutions
EBS
$300M
$300M $5.83 0.34%

Small Cap Drug Manufacturers - Specialty & Generic Stocks at a Glance

Specialty and generic drug manufacturers develop branded niche therapies, off-patent generics, and animal-health and cannabis products. Generics compete on price and manufacturing scale, while specialty brands carry pharma-like margins on smaller markets.

There are 20 small cap Drug Manufacturers - Specialty & Generic stocks — companies in the Drug Manufacturers - Specialty & Generic industry with a market cap between $250M and $2B — worth a combined $20B.

The largest by market cap are BioCryst Pharmaceuticals (BCRX) at $1.92B, Eton Pharmaceutcials (ETON) at $1.81B and Trulieve Cannabis (TRLV) at $1.74B.

Among institutional investors, Eton Pharmaceutcials (ETON) drew the most net new fund positions in Q3 2026: 76 funds opened new positions, taking total fund holders up 49 (30%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q3 2026.